ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Entero Therapeutics Inc

Entero Therapeutics Inc (ENTO)

0.5444
-0.0856
( -13.59% )
Updated: 14:07:29

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.5444
Bid
0.5444
Ask
0.5499
Volume
530,172
0.4249 Day's Range 0.615
0.185 52 Week Range 3.16
Previous Close
0.63
Open
0.615
Last Trade
100
@
0.5444
Last Trade Time
14:07:27
Average Volume (3m)
423,051
Financial Volume
$ 252,278
VWAP
0.475842

ENTO Latest News

Entero Therapeutics CEO James Sapirstein to Moderate the 2024 BioFlorida Annual Innovation Conference CEO Forum

BOCA RATON, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company

Proposed merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing (i) Journey’s next-gen, first-in-class ADC-rivalling, nano-immunoconjugates (“NIC”) platform...

Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings

BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program

BOCA RATON, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease

New VCIEL scale provides a more sensitive and quantitative metric of small intestinal health for monitoring Celiac Disease severity and treatment efficacy Special editorial highlights the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1556-22.22857142860.70.7161990.42494062570.63105266CS
40.00941.757009345790.5350.86550.42492794080.66557704CS
120.124429.6190476190.420.86550.284230510.56034707CS
26-2.4156-81.60810810812.963.160.1854805680.47720261CS
52-2.4156-81.60810810812.963.160.1854805680.47720261CS
156-2.4156-81.60810810812.963.160.1854805680.47720261CS
260-2.4156-81.60810810812.963.160.1854805680.47720261CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MTEMMolecular Templates Inc
$ 0.6208
(92.74%)
292.09M
QUBTQuantum Computing Inc
$ 4.1302
(55.27%)
193.02M
XFORX4 Pharmaceuticals Inc
$ 0.42
(51.46%)
27.9M
OMEROmeros Corporation
$ 6.1412
(46.57%)
12M
SHOTWSafety Shot Inc
$ 0.16
(45.32%)
6.57k
SOWGSow Good Inc
$ 4.115
(-58.05%)
2.38M
NVCTNuvectis Pharma Inc
$ 5.85
(-45.17%)
1.47M
WCTWellchange Holdings Company Limited
$ 4.76
(-39.75%)
784.36k
TRNRInteractive Strength Inc
$ 3.77
(-35.33%)
1.14M
OPRXOptimizeRx Corporation
$ 4.09
(-33.50%)
1.46M
ELABElevai Labs Inc
$ 0.0282
(14.17%)
1.66B
XTIAXTI Aerospace Inc
$ 0.062
(8.39%)
333.33M
MTEMMolecular Templates Inc
$ 0.6208
(92.74%)
292.09M
SVMHSRIVARU Holding Ltd
$ 0.0278
(14.88%)
229M
QUBTQuantum Computing Inc
$ 4.1302
(55.27%)
197.3M

Your Recent History

Delayed Upgrade Clock